Healthcare :: No need for accreditation of hospitals – India
The Government today said it had no intention to go for accreditation of hospitals and labs involved in medical outsourcing and health tourism.
Healthcare
Hepatitis :: Cases of hepatitis B associated with lancing devices
Since 2004, seven cases of hepatitis B have been reported to the Health Protection Agency from care and residential homes following the incorrect use of lancing devices. On further investigation by local Health Protections Units eleven more cases have been identified in diabetics who have probably been infected by these means.
Healthcare :: Federal Agencies Finalize Rules on Health Nondiscrimination
The U. S. Department of Labor?s Employee Benefits Security Administration (EBSA), Internal Revenue Service and Department of Health and Human Services today announced the publication of final rules that provide guidance in complying with the nondiscrimination provisions of the Health Insurance Portability and Accountability Act (HIPAA). The final rules also provide guidance on the implementation of wellness programs.
Healthcare :: United States Officially Accepts New International Health Regulations
HHS Secretary Mike Leavitt today announced the United States has formally accepted the revised International Health Regulations (IHR), and will begin the process of implementing these new international rules immediately instead of waiting for them to take effect in June 2007. Secretary Leavitt made the announcement during a week-long visit to the People?s Republic of China.
Healthcare :: Congressional Action Strengthens Internal Medicine ACP Says
Saturday?s Congressional action to avert Medicare payment cuts to physicians will work to strengthen the future of internal medicine, the American College of Physicians (ACP) said today in a statement of appreciation to lawmakers.
Healthcare :: Licensing Opportunities for Rare Disease Technologies
The National Institutes of Health (NIH) launched a new website today offering technologies available for commercial licensing that are related to rare diseases or conditions. The listing can be found at http://www.ott.nih.gov/rarediseases and currently consists of more than 500 such technologies, including drugs, biologics, and devices, available to be transferred from the NIH and the U.S. Food and Drug Administration (FDA) to the private sector for further research and development and potential commercialization.
Healthcare :: USDA Awards Nearly $1 Million in Food Stamp Outreach Grants
Agriculture Secretary Mike Johanns today awarded nearly $1 million to 14 faith-based and community organizations for their efforts to improve access to, and awareness of, USDA’s Food Stamp Program for eligible low-income households.
Schizophrenia :: ABILIFY, Aripiprazole for Adults With Agitation Associated With Schizophrenia or Bipolar Mania
Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY? (aripiprazole) Injection, an injectable form of ABILIFY, for intramuscular use. ABILIFY Injection provides rapid control of agitation in adults with schizophrenia or bipolar mania at primary endpoint (2 hours).
Breast Cancer :: EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women
Eli Lilly and Company (NYSE: LLY) announced today that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration’s Division of Drug Oncology Products (DDOP) for EVISTA? (raloxifene HCl) for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer.
Healthcare :: GlaxoSmithKline and EPIX Pharmaceuticals enter drug discovery and development alliance
GlaxoSmithKline (GSK) and EPIX Pharmaceuticals today announced a worldwide multi-target strategic collaboration to discover, develop and market novel medicines targeting four G-protein coupled receptors (GPCRs) for the treatment of a variety of diseases, including EPIX?s novel 5-HT4 partial agonist programme, PRX-03140, in early-stage clinical development for the treatment of Alzheimer?s disease. The alliance with GSK will be conducted through its Center of Excellence for External Drug Discovery (CEEDD).